The change in Ki–67 proliferation index from baseline to day 14 was compared to the change in tumor size from the pre-treatment US to the EOT US to determine if the change in Ki–67 at day 14 could be used to predict a change in tumor size over the course of treatment. Here, MKI67 is linked to neoplasm.